JAKARTA - PT Industri Jamu dan Farmasi Sido Muncul Tbk (SIDO) recorded an increase in sales and net profit throughout 2025. SIDO reaped sales of IDR 4.07 trillion, with a net profit of IDR 1.22 trillion throughout last year.
Based on SIDO's financial statements, which were quoted on Monday, March 2, it was stated that sales of Rp4.07 trillion in 2025 increased by 4.10 percent compared to the same period last year of Rp3.91 trillion.
This sale was contributed by herbal medicine and supplements of IDR 2.49 trillion, then the sale of food and beverages worth IDR 1.45 trillion, and pharmaceuticals of IDR 128.2 billion.
On the other hand, the main burden of SIDO's income also increased by 5.96 percent from the previous Rp1.61 trillion in 2024, to Rp1.71 trillion throughout 2025.
The gross profit of the Tolak Angin producer was also recorded as increasing by 2.79% to Rp2.36 trillion, from the previous Rp2.3 trillion on an annual basis.
As a result, the current year's profit attributable to owners of the parent entity of SIDO also increased to IDR 1.22 trillion in 2025. This net profit increased by 4.97 percent compared to the same period last year of IDR 1.17 trillion.
SIDO's basic earnings per share also increased from Rp39.03 in 2024, to Rp41.36 per share in 2025.
SIDO's total assets as of 2025 fell to Rp3.68 trillion, from Rp3.93 trillion in 2024. SIDO's total liabilities rose to the end of 2025 to Rp561.44 trillion, from the previous Rp451.78 trillion at the end of 2024.
Meanwhile, SIDO's total equity decreased from previously Rp3.48 trillion at the end of December 2024, to Rp3.12 trillion at the end of December 2025.
The English, Chinese, Japanese, Arabic, and French versions are automatically generated by the AI. So there may still be inaccuracies in translating, please always see Indonesian as our main language. (system supported by DigitalSiber.id)
